Mesenchymal stem cell-derived extracellular vesicles（Kimera Labs）

N/A

Report date: 2025/02/28 10:17:46

Base Information

Drug NameMesenchymal stem cell-derived extracellular vesicles（Kimera Labs）
Drug Alias NameIsolated, neonatal, mesenchymal stem cell-derived extracellular vesicles（Kimera ）XoGlo
ClassificationBiologics > Exosomes > Stem cell-derived exosomes
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesKimera Labs
China Registration ClassN/A

Develop Information

Active CompaniesKimera Labs
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A